Welcome to our dedicated page for Colony Bankcorp SEC filings (Ticker: CBAN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Colony Bankcorp Inc. finances Georgia’s main streets, from agri-business combines to downtown construction loans, and its SEC disclosures mirror that diverse footprint. If you need Colony Bankcorp insider trading Form 4 transactions or want the loan-to-deposit ratio buried on page 80 of the Colony Bankcorp annual report 10-K simplified, you are in the right place.
Stock Titan’s AI reads every paragraph the moment it hits EDGAR. That means you see Colony Bankcorp Form 4 insider transactions real-time, a Colony Bankcorp quarterly earnings report 10-Q filing with side-by-side credit-quality charts, and Colony Bankcorp 8-K material events explained before the market fully reacts. Our AI-powered summaries translate allowance-for-loan-loss tables into plain English, so understanding Colony Bankcorp SEC documents with AI is faster than scanning hundreds of pages.
Here’s how professionals use this page:
- Credit analysts open the latest Colony Bankcorp earnings report filing analysis to compare non-performing assets quarter-over-quarter.
- Portfolio managers set alerts for Colony Bankcorp executive stock transactions Form 4 to monitor insider sentiment.
- Governance specialists pull the Colony Bankcorp proxy statement executive compensation section to benchmark pay at regional banks.
All filings—10-K, 10-Q, 8-K, Forms 3/4/5, and proxies—are indexed, searchable, and refreshed in real time. Whether you’re tracking dividend capacity, branch acquisitions, or loan-loss provisions, you’ll find Colony Bankcorp SEC filings explained simply, with AI-generated highlights that let you focus on decisions, not document hunting.
Colony Bankcorp, Inc. (CBAN) entered an Equity Distribution Agreement with Piper Sandler & Co. to sell, from time to time, shares of common stock in an at‑the‑market offering of up to $40,000,000, pursuant to its Form S‑3 shelf (if and when declared effective). Sales may be made as at‑the‑market transactions under Rule 415, and may also include privately negotiated transactions or block trades.
The Company will set sale parameters and pay the Agent a commission of up to 3.0% of gross sales. There is no obligation to sell; either party may suspend or terminate the program. Net proceeds are intended for general corporate purposes, including potential capital contributions to Colony Bank to support lending and investing, repayment of indebtedness, and to fund acquisitions and other strategic initiatives permissible for bank holding companies.
Colony Bankcorp (CBAN) reported steady third‑quarter performance. Q3 2025 net income was $5.8 million and EPS was $0.33, compared with $5.6 million and $0.32 a year ago. Net interest income rose to $22.7 million as loan yields outpaced funding costs, while the provision for credit losses was $0.9 million. Noninterest income was stable, with mortgage fees of $1.9 million and a realized $1.0 million loss from securities sales used to reposition the portfolio. Expenses increased to $24.6 million, reflecting higher technology spend and $0.7 million of acquisition-related costs.
The balance sheet expanded: loans, net reached $2.02 billion (from $1.82 billion at year‑end 2024) and deposits totaled $2.58 billion. Accumulated other comprehensive loss improved to $(37.0) million, and stockholders’ equity increased to $302.3 million. Cash and equivalents were $200.0 million. For the first nine months, net income was $20.4 million with EPS of $1.17, supported by net interest income of $66.0 million. Shares outstanding were 17,434,632 as of November 5, 2025.
Colony Bankcorp (CBAN) Chief Banking Officer Ed Canup reported open‑market stock purchases. On 11/03/2025, he bought 500 shares at $15.90 (transaction code P), and on 11/06/2025, he bought 500 shares at $16.25 via his 401(k).
Following these transactions, beneficial ownership was reported as 18,266.63 shares held directly and 8,275 shares held indirectly through a 401(k). The filing notes the direct amount includes shares acquired through reinvested dividends and salary deferral, and the 401(k) amount includes company match, reinvested dividends, and salary deferral.
Colony Bankcorp, Inc. filed a Form S-3 shelf registration to offer up to $150,000,000 of securities from time to time after effectiveness. The base shelf covers common and preferred stock, senior and subordinated debt, depositary shares, purchase contracts, units, warrants, and rights.
An accompanying equity distribution agreement prospectus supplement provides for the offer and sale of up to $40,000,000 of common stock under an at-the-market program with Piper Sandler & Co., which is included within the $150,000,000 shelf capacity. Unsold amounts under the ATM may be offered through other methods under the base prospectus if the agreement is terminated.
Colony’s common stock trades on the NYSE under the symbol CBAN. Shares outstanding were 17,461,284 as of October 30, 2025; this is a baseline figure, not the amount being offered.
Colony Bankcorp (CBAN) insider activity: the company’s Chief Banking Officer reported a Form 4 open-market purchase. On 10/30/2025, the officer bought 500 shares of Colony Bankcorp, Inc. common stock at $15.96 per share (transaction code P).
After the trade, the officer reported 17,766.63 shares of direct beneficial ownership and 7,775 shares of indirect beneficial ownership via a 401(k). The indirect and direct totals include shares acquired through company match, reinvested dividends, and salary deferral, as noted.
Colony Bankcorp (CBAN) reported an insider purchase by its Chief Banking Officer. On 10/24/2025, the reporting person bought 500 shares of Colony Bankcorp, Inc. common stock at $16.587 per share (transaction code P).
Following this trade, the filer beneficially owned 17,266.63 shares directly and 7,775 shares indirectly through a 401(k). The filing notes these amounts include shares acquired through reinvested dividends, salary deferral, and 401(k) company match.
Colony Bankcorp, Inc. (CBAN) furnished an 8‑K announcing it issued a press release with consolidated financial results for the third quarter ended September 30, 2025, and declared a regular quarterly cash dividend. The company also furnished its latest investor presentation.
An investor earnings call is scheduled for 9:00 a.m. ET on October 23, 2025. The materials are provided as Exhibits 99.1 and 99.2 and are furnished, not filed, under the Exchange Act.
BlackRock, Inc. filed an amended Schedule 13G reporting passive ownership of 1,072,582 Colony Bankcorp (CBAN) common shares, representing 6.1% of the class as of 09/30/2025. The firm reports 1,045,090 shares with sole voting power and 1,072,582 with sole dispositive power, with no shared voting or dispositive power.
BlackRock certifies the holdings were acquired and are held in the ordinary course of business and not to change or influence control. Various underlying clients may receive dividends or sale proceeds, and no single client exceeds five percent of outstanding shares.
COLONY BANKCORP, INC. (CBAN) filing shows an insider purchase by CFO Derek Shelnutt. The report discloses a 09/23/2025 acquisition of 25 shares of common stock at a reported price of $17.70 per share. After the purchase, Mr. Shelnutt directly owns 11,626 shares. The filing also states he indirectly owns 5,074 shares through a 401(k) plan, and that some direct holdings include reinvested dividends and salary deferral. The form was signed by an attorney-in-fact on 09/24/2025. This filing reports a routine, small-dollar open-market purchase by a company officer and details ownership breakdown between direct and indirect holdings.
Colony Bankcorp, Inc. and TC Bancshares, Inc. have agreed to combine in a merger under an Agreement and Plan of Merger dated July 23, 2025, with Colony as the surviving public company. TCBC shareholders will receive, at their election, either $21.25 in cash per share or 1.25 shares of Colony common stock, subject to customary proration so that approximately 20% of TCBC shares receive cash and 80% receive stock. The fixed aggregate stock issuance is 3,839,748 shares and former TCBC shareholders are expected to own about 18.0% of the combined company based on September 22, 2025 share counts.
The boards of both companies unanimously recommend approval. Closing remains subject to TCBC and Colony shareholder approvals, customary regulatory and closing conditions, allocation/proration procedures for elections, and certain anti-dilutive and fractional-share adjustment mechanics described in the proxy/prospectus.